Background: The prognosis of hyperproliferative pores and skin lesions, resembling psoriasis, basal cell carcinoma and nonmelanoma pores and skin cancers, is considerably benefited from the degrees of Tazarotene-induced gene-1 (TIG3) expression and subsequent therapy with tazarotene. Such observations counsel that TIG3
